Harvard Bioscience Liabilities 2024

Harvard Bioscience Aktienanalyse

What does Harvard Bioscience do?

Harvard Bioscience Inc was founded in 1901 and is headquartered in Holliston, Massachusetts. The company is a global leader in providing instruments, technologies, and complete systems for science and research. Harvard Bioscience has established itself as one of the leading providers of products and solutions in the fields of life sciences and health research with over 100 years of industry experience. The business model of Harvard Bioscience is focused on delivering high-quality products and solutions for research needs. The company is divided into three business segments: Life Science Research Products, Preclinical Surgical Products, and Analytical Instruments. These business segments offer a variety of products, such as instruments for cell and molecular research, gene expression analysis devices, surgical instruments, and instruments for electrophysiology. The Life Science Research segment includes the business units Harvard Apparatus, Molecular Devices, and Denville Scientific. Harvard Apparatus provides instruments for cell and molecular research, physiological instruments, and animal model systems. Molecular Devices specializes in instrumental analysis methods for cell and molecular research. Denville Scientific is a leading supplier of products for cell and molecular biology, including materials for gene and protein expression and cell culture techniques. In the Preclinical Surgical Products segment, Harvard Bioscience operates with the company Hugo Sachs Elektronik. Surgical instruments and complete systems for preclinical research are offered here. These products are popular among scientists worldwide as they have been developed for conducting research with animal models. Analytical Instruments is the segment where the company operates joint ventures to develop instruments for physical, material, and life science research. In this segment, Harvard Bioscience is primarily involved in the joint venture Wasatch Microfluidics, alongside Agilent Technologies, which specializes in the development of instruments for life sciences and biotechnology. As a provider of science and research-related instruments and devices, Harvard Bioscience has a wide range of products to help researchers and scientists enhance their work more effectively. Some of the most popular products from Harvard Bioscience include tissue processing systems, neuroprotection applications, animal model holders, and electrophysiology platforms. Harvard Bioscience also offers a range of products for quality assurance and environmental protection, such as cleanroom and protection devices for material preparation and sterilization. Overall, Harvard Bioscience Inc has an excellent reputation in the industry and is one of the world's leading companies for scientific and research-related products and services. The company constantly strives to improve its products and services and adapts to the needs of its customers. It relies on innovation and continuously works to develop and implement new technologies to meet the demands of the scientific world. Harvard Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Harvard Bioscience's Liabilities

Harvard Bioscience's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Harvard Bioscience's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Harvard Bioscience's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Harvard Bioscience's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Harvard Bioscience’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Harvard Bioscience Stock

What is the level of liabilities of Harvard Bioscience this year?

Harvard Bioscience has a debt balance of 64.29 M USD this year.

What were the liabilities of Harvard Bioscience compared to the previous year?

The liabilities of Harvard Bioscience have increased by -12.05% dropped compared to the previous year.

What are the consequences of high debt for investors of Harvard Bioscience?

High liabilities can pose a risk for investors of Harvard Bioscience, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Harvard Bioscience?

Low liabilities mean that Harvard Bioscience has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Harvard Bioscience affect the company?

An increase in liabilities of Harvard Bioscience can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Harvard Bioscience affect the company?

A decrease in the liabilities of Harvard Bioscience can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Harvard Bioscience?

Some factors that can influence the liabilities of Harvard Bioscience include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Harvard Bioscience so important for investors?

The liabilities of Harvard Bioscience are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Harvard Bioscience take to modify the liabilities?

To change its liabilities, Harvard Bioscience can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Harvard Bioscience pay?

Over the past 12 months, Harvard Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Harvard Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Harvard Bioscience?

The current dividend yield of Harvard Bioscience is .

When does Harvard Bioscience pay dividends?

Harvard Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Harvard Bioscience?

Harvard Bioscience paid dividends every year for the past 0 years.

What is the dividend of Harvard Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Harvard Bioscience located?

Harvard Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Harvard Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Harvard Bioscience from 6/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/1/2024.

When did Harvard Bioscience pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Harvard Bioscience in the year 2023?

In the year 2023, Harvard Bioscience distributed 0 USD as dividends.

In which currency does Harvard Bioscience pay out the dividend?

The dividends of Harvard Bioscience are distributed in USD.